A novel cardiometabolic therapeutic prospect Cardiometabolic diseases as diabetes mellitus, heart disease, overweight, obesity, hypertension, hyperlipidemia and its multiple macro and microvascular complications (ischemic cardiomyopathy, stroke, chronic kidney disease, retinopathy, peripheral neuropathy, etc.) are conditions closely related to each other and constitute at present time the leading cause of morbility, disability and death in the world [28]
Weight loss treatment options include everything from prescription drugs such as Ozempic and Wegovy to compounded and GLP-1s
On GLP-1 medications, which suppress your appetite, hitting the right protein target helps ensure that most of the weight you lose comes primarily from fat
June 19, 2017
Reviewing the mechanism of actionspecifically how it influences hunger, fullness, satisfaction, and food cravingscan help patients understand that weight loss results from a medication-induced calorie deficit, not from burning fat or boosting metabolism